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Peptidases are enzymes that hydrolyse peptide bonds in proteins and peptides. Peptidases are important in pathological
conditions such as Alzheimer’s disease, tumour and parasite invasion, and for processing viral polyproteins. The MEROPS
database is an Internet resource containing information on peptidases, their substrates and inhibitors. The database now
includes details of cleavage positions in substrates, both physiological and non-physiological, natural and synthetic. There
are 39118 cleavages in the collection; including 34606 from a total of 10513 different proteins and 2677 cleavages in
synthetic substrates. The number of cleavages designated as ‘physiological’ is 13307. The data are derived from 6095
publications. At least one substrate cleavage is known for 45% of the 2415 different peptidases recognized in the
MEROPS database. The website now has three new displays: two showing peptidase specificity as a logo and a frequency
matrix, the third showing a dynamically generated alignment between each protein substrate and its most closely related
homologues. Many of the proteins described in the literature as peptidase substrates have been studied only in vitro.O n
the assumption that a physiologically relevant cleavage site would be conserved between species, the conservation of every
site in terms of peptidase preference has been examined and a number have been identified that are not conserved. There
are a number of cogent reasons why a site might not be conserved. Each poorly conserved site has been examined and a
reason postulated. Some sites are identified that are very poorly conserved where cleavage is more likely to be fortuitous
than of physiological relevance. This data-set is freely available via the Internet and is a useful training set for algorithms to
predict substrates for peptidases and cleavage positions within those substrates. The data may also be useful for the design
of inhibitors and for engineering novel specificities into peptidases.
Database URL: http://merops.sanger.ac.uk
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Introduction
Peptidases (proteases or proteinases) are enzymes that
hydrolyse the peptide bonds between amino acids in a pro-
tein or peptide chain. Hydrolysis of such bonds is required
for removal of targeting signals (signal and transit peptides
(1), ubiquitin (2), SUMO (3) and NEDD8 (4) peptides),
the release of a mature protein from its precursor (5), the
switching off of a biological signal by degradation of the
signal protein (6), and for widespread catabolism of pro-
teins for recycling of the amino acids. When proteolysis
occurs unchecked, then diseases can result, such as
Alzheimer’s (7), osteoarthritis (8), emphysema (9), tumour
invasion (10) and acute pancreatitis (11). Pathogens use
peptidases to enter the host and to degrade host proteins
for food (12).
Peptides and proteins have been widely used to charac-
terize the specificity of peptidases, but frequently the sub-
strates chosen have been physiologically irrelevant. One of
the most popular substrates has been the oxidized insulin
B-chain, because this is a peptide without tertiary structure,
and cleavage depends solely on the preference of the pep-
tidase (13). (The terms ‘specificity’, ‘selectivity’ and ‘prefer-
ence’ are used interchangeably here.) However, peptidase
preference is exactly that: a preference only. Researchers
often find that after prolonged exposure to a peptidase
other bonds are degraded, albeit slowly, once none of
the preferred bonds remain. If the peptidase preparation
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observed cleavages are due to contaminating peptidases.
The bond in a substrate where hydrolysis occurs is known
as the ‘scissile bond’. In the Schechter and Berger nomen-
clature (14), residues on the left-hand side of the scissile
bond (towards the N-terminus) are numbered P1, P2, P3,
etc. and residues on the right-hand side (towards the
C-terminus) are numbered P10,P 2 0,P 3 0, etc. with cleavage
occurring between P1 and P10. The substrate-binding
pocket in the peptidase that accommodates the P1 residue
is known as the S1 pocket, and that accommodating the P10
residue is the S10 pocket.
Predicting where a peptidase will cleave in a native pro-
tein is difficult. Where cleavage does occur in a protein is
due to a combination of the preference of the peptidase
and the availability of bonds in the substrate. Although the
preference of the peptidase can be quite simple, for exam-
ple trypsin (MEROPS identifier S01.151) cleaves lysyl and
arginyl bonds (15) and caspase-3 (C14.003) cleaves only
aspartyl bonds (16), very often peptidase preference is cryp-
tic. It is relatively easy to predict trypsin cleavages in a
denatured protein, but few lysyl and arginyl bonds will be
cleaved in a native protein. This has proved useful for
researchers wishing to separate structural domains in a
multidomain protein using limited proteolysis (17). It is
not possible to predict where in a peptide cathepsin B
(C01.060) will cleave, for example, despite its known pre-
ferences for a hydrophobic residue in the S2 pocket and
arginine in S1 (18).
Even though for some peptidases the specificity has been
clearly defined, in all probability only a few bonds will be
susceptible to cleavage in a mature protein. A protein will
have few bonds flexible enough to thread into a peptidase
active site if the protein is in a native state, because of the
stabilizing interactions within and between secondary
structure elements within the substrate. It is widely
assumed that the susceptible bonds will be within surface
loops and interdomain connectors. However, once a bond is
cleaved and the tertiary structure perturbed, further bonds
may become susceptible.
Most studies of the action of a peptidase on a supposed
physiological substrate are performed in vitro. It may be,
however, that in vivo peptidase and substrate do not meet,
either because of a physical boundary, such as being in
different intracellular (or extracellular) compartments,
because inhibitors inactivate the peptidase, the cleavage
sites are inaccessible because the substrate is bound to
another protein, or the environment is unsuitable and the
peptidase is not active.
Despite the importance of protein cleavage, there has
been no centralized repository for cleavage data collection
and no attempt to curate these cleavages by mapping them
to residue positions in protein primary sequence databases.
Given that nearly all proteins are eventually degraded, and
that any one protein can be degraded by several different
peptidases often by cleavages at multiple peptide bonds,
the potential total number of cleavages will always exceed
the number of known proteins. Up until recently each
cleavage had to be characterized biochemically, which
meant N-terminal sequencing of the products, a time-
consuming and labour-intensive task. Now that proteomic
analyses are possible, where cell lysates or similar samples
are subjected to cleavage by a peptidase, peptides isolated,
composition determined by mass spectroscopy, and possi-
ble source protein(s) determined from the composition (19),
the amount of data is set to rise exponentially. This makes it
vitally important that the information be accurately stored
and curated. Such a collection made readily available would
provide a comprehensive training set for algorithms and
software for the prediction of physiological substrates
and cleavage positions.
The classification of peptidases into clans and families
was first published in 1993 (20), and this was converted
into an Internet resource, the MEROPS database (21), in
1996. The database was extended to include nomenclature
and bibliographies, and has been developed over the years
to be a one-stop shop for researchers with an interest in
proteolysis. The collection of known cleavages in substrates
which was started in 1998 (22) has now been added to the
MEROPS database. For each peptidase there is a page list-
ing known substrates, and, where enough substrates are
known, the peptidase summary has displays to show pepti-
dase specificity. For each protein substrate, the sequence is
displayed showing where cleavage occurs and which pepti-
dase performs that cleavage. In addition to the MEROPS
collection, there is also a collection of physiologically rele-
vant protein cleavages assembled by the CutDB database
(23) and more specialist collections of substrates for individ-
ual peptidases or peptidase families, such as CASBAH for
caspases (24).
Methods
Data collection and curation
The primary source of protein cleavage information is the
published literature. Search profiles have been developed
for use at PubMed (25) and Scopus (http://info.scopus.com/).
These are updated regularly and currently include  500
names that are known to be used for peptidases. These
retrieve a set of  250 potentially interesting abstracts
each week. There is much redundancy, in that a single arti-
cle may be retrieved by several search terms. Once a non-
redundant list of articles has been obtained, the abstracts
are reviewed to select the subset that is to be included in
MEROPS. In a typical week, 50–60 references come through
this filter. Keywords, including the MEROPS identifiers for
the relevant peptidases, are manually attached to each and
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appear on. If from the abstract it is clear that the paper
contains substrate-cleavage data these are entered imme-
diately into the MEROPS collection. Periodically, the bibli-
ography in MEROPS for a peptidase is reviewed to find
substrate cleavages with a preference for peptidases with-
out any substrates in the MEROPS collection.
If the substrate is a protein, it is mapped to a UniProt
protein sequence database entry (26) initially by name and
species. Each cleavage in the protein is mapped to a specific
residue in the UniProt entry. Frequently the residue number
reported in the paper refers to a position in the mature
protein, and to map this to the UniProt sequence the
length of any signal peptide and/or propeptide has to be
added. The UniProt accession, the P1 residue number, the
CRC64 checksum for the sequence and the MEROPS identi-
fier for the peptidase are stored. In addition other informa-
tion may be retained, including whether the cleavage is
deemed by the authors of the source paper to be physio-
logical or not, whether the substrate was in native confor-
mation, the pH of the reaction, and the method used to
identify the cleavage. The four residues either side of the
scissile bond are also stored so that the cleavage position
can be recalculated should the UniProt protein sequence
change, and to provide the data for what amino acids are
acceptable in the binding pockets S4–S40 for each pepti-
dase. A bespoke program (in Perl) was written to add
each cleavage in a protein substrate to ensure consistency;
the program connects to the locally installed version of
UniProt so that each cleavage position can be confirmed
as the data are entered. Some data were acquired from
proteomics studies. Again a bespoke program was written
to parse the data from the Excel spreadsheets available as
Supplementary Data to the published papers. Some cleav-
ages were acquired from the CutDB database, but these
have been manually checked against the original reference
and the UniProt sequence. Once again a bespoke program
was written to collect the data, translate the provided sub-
strate Protein Identifier to a Uniprot accession, check that a
cleavage event was not already present in the MEROPS
collection (and add the CutDB accession number if it
were), and add new cleavage events to the MEROPS collec-
tion, reporting any inconsistency between the P4–P40 resi-
dues and the sequence in the UniProt entry.
The data collected are non-redundant. If more than one
paper reports the cleavage at the same position in the same
protein by the same peptidase, then only data from the
paper published first is retained. If several peptidases
cleave the same protein in the same position, each is con-
sidered a different cleavage event and each is entered.
There is no attempt to map cleavages to isoforms of a pro-
tein, unless different isoforms were used by the original
researchers. Synthetic substrates that differ only in leader
(for example benzyloxycarbonyl, succinyl or tosyl) or
reporter groups (for example aminomethylcoumarin,
naphthylamide or nitroanilide) are considered different
cleavages even if all are performed by the same peptidase.
Specificity displays
The MEROPS website has two displays to show peptidase
specificity. Both use the data from natural and synthetic
substrates, but show only naturally occurring amino acids.
The first display is a logo which uses the WebLogo software
(27). Residues P4–P40 from all the substrates for a peptidase
are treated as an alignment. The observed frequency for
each amino acid in each position is calculated as a bit score,
the maximum possible being 4.32 bits. An amino acid is
shown in the logo (in single-letter code) if the bit score
exceeds 0.1. The logo is also shown as a text string, where
if a single amino acid predominates at one position (i.e. the
bit score exceeds 0.4) the letter is shown in uppercase, and
if more than one amino acid predominates in any position a
letter is shown in uppercase when the bit score exceeds 0.7
and in lower case if the bit score is between 0.1 and 0.7.
The second display is a frequency matrix, which is an
8 20 matrix with residues P4–P40 along the x-axis and all
amino acids along the y-axis. The amino acids are ordered
so that those with similar properties are adjacent. The order
is Gly, Pro, Ala, Val, Leu, Ile, Met, Phe, Tyr, Trp, Ser, Thr, Cys,
Asn, Gln, Asp, Glu, Lys, Arg and His. Preference is calculated
in terms of the percentage of substrates with each amino
acid in each position, and a different shade of green is used
for each tenth percentile interval. The number of times a
residue occurs at each position is shown.
Sequence alignments
The UniProt accession for each substrate with a known
cleavage site was used to search the UniRef50 database
(clusters of sequences that have at least 50% sequence
identity to the longest sequence) (28). If a UniRef50 entry
was found, then all the UniProt accessions included in that
entry were extracted and the sequences retrieved from the
UniProt database in FastA format. Short fragments were
excluded and the remaining sequences were then aligned
with MUSCLE (29), using the default parameters and per-
forming two iterations over the complete alignment to
minimize gaps. Because each UniRef50 entry contains
sequences sharing 50% or more sequence identity, the pro-
gram is very quick, and the resulting alignment approxi-
mates to an alignment of orthologues. However, some
UniRef50 entries will also contain closely related
paralogues.
Sequence alignments were generated and highlighted to
show not just conserved residues but also peptidase prefer-
ence. For each cleavage the residues P4–P40 were high-
lighted to indicate whether the residue in each sequence
had been observed in any substrate at that position for the
peptidase in question. Residues identical to the sequence
.............................................................................................................................................................................................................................................................................................
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ground. Replacements observed in other substrates are
shown with an orange background. Where no substrate
for this peptidase is known with this amino acid in this
position the residue is shown with a black background.
The term ‘atypical’ is used for an amino acid that has not
been observed in a particular binding pocket in any known
substrate for a peptidase.
Results and discussion
The MEROPS cleavage collection
The MEROPS cleavage collection contains 39118 cleavages
(as of 7 August 2009). The number of cleavages that can be
mapped to entries in the UniProt database is 34606, the
remaining 4512 consisting mainly of synthetic substrates.
The number of different entries in the UniProt database
to which cleavages are mapped is 10513. The number
of cleavages that are designated as ‘physiological’ is
13307; whereas 20187 cleavages are designated ‘non-
physiological’ and 2677 cleavages are designated ‘syn-
thetic’. The remaining 2947 are cleavages in peptides that
can not be mapped to UniProt because: they are too short;
they are significantly modified, such as the non-alpha pep-
tide bond between ubiquitin and its target protein; they
are derived from phage displays; they are theoretical
cleavages or because it is unclear whether the cleavage is
physiological or not. The data are derived from 6095 pub-
lications. The number of cleavages in common between the
MEROPS and CutDB collections is 5876, of which 3424 were
originally found in the literature by the CutDB researchers.
The number of cleavages from the CutDB database that
failed to make the MEROPS collection, excluding 892 iso-
forms and 35 duplicates, was 560 (9.5%), mostly due to
being mapped to the wrong residue or sequence. The
CutDB curators have been informed of these discrepancies.
Because the CutDB database includes only cleavages
thought to be of physiological relevance and those that
can be included in their proteolytic pathways, it has fewer
cleavages than in the MEROPS collection. It does not
include cleavages in synthetic substrates and those peptides
used solely to map peptidase specificities, or general pur-
pose processing enzymes such as signal peptidases and
methionyl aminopeptidases.
There are 2415 different peptidases recognized in the
MEROPS database (excluding hypothetical peptidases
from model organisms). Substrate cleavages have been col-
lected for 1086 peptidases (45%); for the remainder any
cleavage positions in substrates are either unknown or
have not yet been found in the literature. Only 312 pepti-
dases have had ten or more cleavages collected, and it is
only these for which there is enough data for further anal-
ysis. The total number of cleavages for these 312
peptidases is 33047. The peptidases with most cleavage
data collected are (the MEROPS identifier and number of
cleavages are given in parenthesis after the name): trypsin
1 (S01.151; 13558), matrix metallopeptidase-2 (M10.003;
2227), eukaryotic signal peptidase complex (XS26-001;
1801), glutamyl peptidase I (S01.269; 1213), HIV-1 retropep-
sin (A02.001; 1059), methionyl aminopeptidase 1 (M24.001;
564), cathepsin G (S01.133; 448), chymotrypsin A (cattle-
type) (S01.001; 445), caspase-3 (C14.003; 414), elastase-2
(S01.131; 400), signalase (animal) 21kDa component
(S26.010; 363) and granzyme B (Homo sapiens-type)
(S01.010; 358).
Peptidase specificity
The residues from P4–P40 were collected for each substrate
cleavage. Figure 1 shows the number of peptidases show-
ing some selectivity for one or two residues in each binding
pocket from S4 to S40. Clearly, many peptidases have
extended substrate-binding sites with preferences beyond
S1, with 52 showing a preference in the S4 pocket. There
are a few peptidases that have a preference at S5 (30), but
a preference so far from the scissile bond is rare. It is con-
ceivable that mitochondrial intermediate peptidase
(M03.006), which removes a transit octapeptide from the
N-terminus of proteins synthesized in the cytoplasm but
destined for the mitochondrial matrix, may have a prefer-
ence as far away from the cleavage site as S8 (31).
Preference on the prime side of the scissile bond is thought
to rarely extend beyond the S10 pocket, but Figure 1 shows
that 32 different peptidases have a preference in S40.
Exopeptidases cleave near protein termini, and because
the binding pockets do not exist are unable to accept any
amino acids in some positions. Dipeptidases can only accept
residues in the S1 and S10 pockets; aminopeptidases are
unable to accept any residue in S4–S2, carboxypeptidases
in S20–S40, dipeptidyl-peptidases in S4 and S3, tripeptidyl-
peptidases in S4 and peptidyl-dipeptidases in S30 and S40.
Some omega peptidases (peptidases which do not cleave
normal peptide bonds but release substituted amino acids
such as pyroglutamate or cleave isopeptide bonds, such as
many deubiquitinating enzymes) may also be unable to
accept any residue in certain positions, or it is not possible
to interpret cleavages in terms of P4–P40, for example for
isopeptidases. There are 36 peptidases with 10 or more
cleavages that cannot accept any residue in S4, 35 for S3,
26 for S2, 15 for S20, 22 for S30 and 25 for S40.
Table 1 shows the number of peptidases showing some
selectivity in each binding pocket from S4 to S40 for amino
acid properties (where ‘acidic’ is Asp or Glu; ‘basic’ is Arg,
His or Lys; ‘aliphatic’ is Ile, Leu or Val; ‘aromatic’ is Phe, Trp
or Tyr; and ‘small’ is Ala, Cys, Gly or Ser). Properties are
taken from Livingstone and Barton (32). Only the cate-
gories with the fewest amino acids, and those that do not
overlap (with the exception of His, which can also be
.............................................................................................................................................................................................................................................................................................
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‘hydrophobic’ and ‘polar’ are used then nearly every bind-
ing pocket is highlighted because each category contains
more than half of the amino acids. Most preference is direc-
ted towards the S1 (201 different peptidases) and S10 (160
different peptidases) pockets. The commonest preferences
are for a basic amino acid in the P1 position, small amino
acids in P1 and P10, and an aliphatic amino acid in P10.N o
aromatic amino acids were observed in P40 in any of the
substrates of these 312 peptidases. For each amino acid
category preference was most pronounced in the S1
pocket with the exception of aliphatic amino acids, where
most peptidases have a preference in the S10 pocket.
Preference for acidic amino acids is very rare except in the
S1 pocket, and similarly aromatic amino acids are rarely
preferred except in S1 and S10.
The preference for individual amino acids is shown in
Table 2. It is clear from the table that cysteine is an
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Figure 1. Preference for amino acids in substrate binding sites.
The bar chart shows the number of peptidases showing a pref-
erenceforoneortwoaminoacidsforeachsubstratebindingsite
S4–S40. Of the 312 peptidase with 10 or more known substrate
cleavages, 202 show a preferenceand are included in the figure.
A count is made whenever an amino acid occurs in one binding
pocketin40%ormoreofthesubstrates.Thereare15peptidases
that have a preference for two amino acids in a binding pocket:
walleye dermal sarcoma virus retropepsin (A02.063, Asn or Gln
in S2), sapovirus 3C-like peptidase (C24.003, Glu or Gln in S1),
SARS coronavirus picornain 3C-like peptidase (C30.005, Gly or
Gln in S1), peptidyl-peptidase Acer (M02.002, Gly or Pro in S1),
vimelysin (M04.010, Phe or Leu in S1), carboxypeptidase
M (M14.006, Arg or Lys in S10), carboxypeptidase U (M14.009,
Arg or Lys in S10), dactylysin (M9G.026, Leu or Phe in S10),
chymase (S01.140, Phe or Tyr in S1), tryptase alpha (S01.143,
Lys or Arg in S1), trypsin 1 (S01.151, Lys or Arg in S1), plasmin
(S01.233, Lys or Arg in S1), flavivirin (S07.001, Lys or Arg in S2),
dipeptidyl aminopeptidase A (S09.005, Ala or Pro in S1) and
kumamolisin (S53, 004, Glu or Gly in S3). Many peptidases
show a preference in more than one binding pocket. There are
13 peptidases with a preference for all eight binding pockets,
another 13 with a preference in seven, five peptidases in six,
three in five, eight in four, 24 in three, 47 in two and 89 in
only one.
Table 2. Number of peptidases with an amino acid preference
Amino acid S4 S3 S2 S1 S10 S20 S30 S40
Ala 6 8 5 10 8 5 1
Cys 1 1
Asp 3 16 2 3
Glu 1 7 5 8 1 1 2
Phe 2 1 5 12 10 2
Gly 3 1 11 17 12 2 6 5
His 1 2
Ile 2 1 8 1
Lys 2 4 8 6 6 2 4
Leu 11 4 9 12 24 4 7
Met 1 6
Asn 9 1
Pro 2 8 5 9 9 4 1 4
Gln 9 1 5 1 10
Arg 8 1 2 52 5 3 1
Ser 8 1 8 3 2 1
Thr 3 1 1 1
Val 1 6 1 2 5 6 11 5
Trp 1 1
Tyr 11 1 5
The number of peptidases showing a preference for an amino
acid in a binding site is shown. Only those 312 peptidases with
10 or more known substrate cleavages are included. An amino
acid must occur at that position in 40% or more of substrates.
Therefore, it is possible for two amino acids to be preferred in
any one binding pocket, as is the case for trypsin 1 where there is
a preference for either Lys (59% of substrates) or Arg (41%) in S1.
There are 202 peptidases that show a preference, of which 13
show a preference at all eight sites, 13 for seven sites, five for
six sites, three for five sites, eight for four sites, 23 for three sites,
49 for two sites and 88 for one site.
Table 1. Peptidase preference by amino acid type
Amino acid type S4 S3 S2 S1 S10 S20 S30 S40
Acidic 5 7 5 24 5 4 2 5
Basic 11 8 13 67 11 9 5 2
Aliphatic 22 24 32 18 56 36 23 7
Aromatic 2 2 8 34 23 7 1 0
S m a l l 3 5 3 4 3 15 86 5 2 2 2 6 2 0
Total 75 75 89 201 160 78 57 34
The number of peptidases with a preference for a particular
amino acid type for each binding pocket S4–S40 is shown, where
40% or more of substrates have an amino acid of that type at
that position. Only those 312 peptidases with at least 10 known
cleavages are included. There are 276 peptidases that show a pref-
erence, of which 18 show a preference at all eight sites, 16 for
seven sites, 12 for six sites, 17 for five sites, 33 for four sites, 46 for
three sites, 64 for two sites and 70 for one site.
.............................................................................................................................................................................................................................................................................................
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oxisomal transit peptide peptidase shows a preference for
cysteine binding to the S2 and S1 pockets. Tryptophan is
also rare around cleavage sites, with only tryptophanyl ami-
nopeptidase (M9A.008, a preference in the S1 pocket) and
mast cell peptidase 4 (Rattus) (S01.005, in the S2 pocket)
showing a preference; however, this may have more to
do with the fact that tryptophan is the rarest of the
amino acids. Asparagine is also very rare in the proximity
of a cleavage site, one of the few examples being the spe-
cialist peptidase legumain (C13.006) which only cleaves
asparaginyl bonds (33). Histidine is also a rare preference,
with only three peptidases showing any preference for it,
namely chymosin (A01.006; S4), carnosine dipeptidase I
(M20.006; S10) and Xaa-methyl-His dipeptidase (M20.013;
S10). Methionine is also not preferred by most peptidases,
exceptions being methionyl aminopeptidases (M24.001,
M24.002), where the preference is as expected for methio-
nine binding in the S1 pocket, some members of the pepti-
dase Clp family (S14) and the unsequenced Met-Xaa
dipeptidase (M9B.004). The gpr peptidase (A25.001) shows
a preference for Met binding to S4. The commonest pref-
erence is for arginine binding to the S1 pocket, which
occurs in over fifty peptidases. However, arginine is rela-
tively rare outside the P1 position. There are peptidases
that show a preference for Gly, Pro and Val for every bind-
ing pocket in the range S4–S40. Peptidases showing unique
preferences are listed in Table 3.
Despite there being a large number of substrates col-
lected, the specificity of some peptidases can not be
explained in terms of S4–S40 preferences. These peptidases
include (MEROPS identifier and number of substrate clea-
vages in brackets): cathepsin D (A01.009; 145), cathepsin E
(A01.010; 64), nemepsin-2 (A01.068; 127), papain (C01.001;
40), cathepsin X (C01.013; 24), cathepsin L (C01.032; 85),
cathepsin B (C01.060; 82), aspergilloglutamic peptidase
(G01.002; 37), mirabilysin (M10.057; 32), neprilysin
(M13.001; 83), endothelin-converting enzyme 1 (M13.002;
27), MEP peptidase (M13.011; 43), pitrilysin (M16.001; 23),
insulysin (M16.002; 31), eupitrilysin (M16.009; 54), amino-
peptidase Ap1 (M28.002; 66), plasma glutamate carboxy-
peptidase (M28.014; 33), penicillolysin (M35.001; 20),
Table 3. Peptidases showing unique preferences
Peptidase name MEROPS ID Total
substrate
cleavages
S4 S3 S2 S1 S10 S20 S30 S40
Chymosin A01.006 15 His Ser Ile
Feline immunodefiency virus
retropepsin
A02.007 28 Val
Walleye dermal sarcoma
virus retropepsin
A02.063 27 Gln
PibD peptidase A24.017 10 Thr
gpr peptidase A25.001 32 Met Ile Glu
Cruzipain C01.075 49 Arg
Coxsackievirus-type picornain 3C C03.011 10 Pro
Ubiquitinyl hydrolase-L3 C12.003 14 Arg
Legumain C13.004 30 Asn
Sapovirus 3C-like peptidase C24.003 10 Thr
Separase (yeast-type) C50.001 12 Glu
Peptidyl-dipeptidase Acer M02.002 10 Phe
Bacterial collagenase H M09.003 18 Ala
PrtA peptidase (Photorhabdus-type) M10.063 23 Glu
ADAM8 peptidase M12.208 22 Gln
Tryptophanyl aminopeptidase
(Trichosporon cutaneum)
M9A.008 15 Trp
Carboxypeptidase G3 M9E.007 12 Glu
Mast cell peptidase 4 (Rattus) S01.005 33 Trp
Kumamolisin S53.004 10 Val Gly Tyr
Peroxisomal transit peptide
peptidase
U9G.062 14 Cys Cys
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.............................................................................................................................................................................................................................................................................................deuterolysin (M35.002; 22), FtsH peptidase (M41.001; 24),
dipeptidyl-peptidase III (M49.001; 24), glycyl aminopepti-
dase (M61.001; 26), chymotrypsin C (S01.157; 20), kallikrein
1 (S01.160; 25), subtilisin Carlsberg (S08.001; 33), high alka-
line protease (Alkaliphilus transvaalensis) (S08.028; 28),
peptidase K (S08.054; 43) and signalase (animal) 21kDa
component (S26.010; 363).
Displays on the MEROPS website
Specificity logos and frequency matrices present the user
with a visual representation of peptidase specificity.
An example specificity logo is shown in Figure 2. From
the logo and the cleavage pattern string it is clear that
caspase-3 has an absolute requirement for Asp in the S1
pocket (position 4, only one cleavage after Glu is known)
and a preference for Asp in S4. There are minor preferences
for Glu in S3 and Gly or Ser in S10.
While the logo indicates which amino acids are accept-
able in each position, it does not indicate which amino acids
are unobserved. These are shown in the frequency matrix,
and an example is also shown in Figure 2 for caspase-3. In
this example Asp occurs in the P1 position in all 413 sub-
strates, Asp occurs in P4 in almost half the substrates, while
Glu occurs in P3 in 27% of substrates. Note that in this fre-
quency matrix every amino acid occurs in positions P4–P2
and P10–P40, but tryptophan is observed only once in P4, P2,
P10 and P40. This gives an indication of the minimum
number of substrate cleavages that has to be collected
for a peptidase before definite conclusions about specificity
in all binding pockets can be drawn.
A substrate alignment is shown in Figure 3. The density
of residues highlighted in black is high, implying that this
cleavage position is very poorly conserved and thus may not
be physiologically relevant.
Figure 2. The specificity logo and frequency matrix showing the substrate specificity of caspase-3. The figure is taken from a
page in the MEROPS database. The logo is shown at the top with the frequency matrix below. The cleavage pattern is a textual
representation of the logo, where the scissile bond is shown as a red cross, and the binding pockets separated by forward
slashes. The preferred residue is shown in uppercase if the preference is strong. The number of cleavages on which these data
are based is given in parentheses. For the logo, the binding pockets S4–S40 are shown along the x-axis, where 1 is S4, 2 is S3, etc.
The bit score is shown on the y-axis. The height of the letter is proportional to the bit score. The letters are coloured to indicate
amino acid properties: blue for basic, red for acidic, black for hydrophobic and green for any other. In the frequency matrix
below the logo, each cell shows the number of substrates with an amino acid occupying one of the positions P4–P40. Cells in the
matrix are highlighted in shades of green where the greater the preference, i.e. the more often an amino acid occurs at that
position, the brighter the shade. Cells are highlighted in black if the amino acid is unknown at that position for any substrate.
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conserved
Protein sequence alignments were constructed for every
substrate where the cleavage had been assumed in the lit-
erature to be of physiological significance. The total
number of alignments generated was 3141. A selection of
cleavage sites which were not conserved in all homologues
included in the same UniRef50 database entry are listed in
Table 4. Only those cleavages by peptidases with at least 20
known substrates are included.
There are a number of possible causes for a cleavage site
not to be conserved which are listed below.
(1) The UniRef50 entry might include paralogous
sequences which although at least 50% identical to
the sequence with the known cleavage, might be pro-
cessed or degraded differently and there is no evolu-
tionary pressure to maintain the known cleavage site.
Where a cleavage site was not conserved, a paralogue
was identified in an alignment as a second protein
from the same species that was clearly not a splice
variant.
(2) UniRef50 entries contain many translated genes from
genome sequencing projects; gene finding in eukar-
yote genomes is notoriously difficult and it is possible
that erroneous gene building has resulted, for exam-
ple, in the loss of the exon encoding the cleavage site
or the inclusion of part of an intron in its place.
(3) It is also probable that for some peptidases there
are not enough substrates known to be sure that
any amino acid is really excluded from a particular
binding site. The number of substrates known for
each peptidase is included in Table 4, because the
greater the number of substrates the more likely
that an amino acid is really atypical and not just
unobserved.
(4) The alignment is incorrect. This is unlikely given the
close relationship between the sequences, which are
all 50% or more identical; however there are situa-
tions where an insert or deletion occurs within the
range P4–P40.
(5) Some endogenous cleavages (for example removal of
signal and transit peptides) may be the result of more
than one cleavage, because aminopeptidases nibble
away the N-terminus (1), and may thus be incorrectly
mapped to the specificity of the leader peptidase.
(6) It is theoretically possible that if the substrate and
peptidase are from the same organism both will
have evolved to accommodate a change in the cleav-
age position.
(7) A single residue mismatch may also be due to a
single-base sequencing error. Potential errors of this
kind can be identified using a codon dictionary, pro-
vided the atypical residue could be the result of a
single base change, and that it is the only residue
not conserved, regardless of the number of sequences
in the alignment.
(8) Some cleavages regarded as ‘physiological’ are actu-
ally fortuitous. If a cleavage site is extremely poorly
conserved it is unlikely to be physiologically relevant.
Figure 3. Alignment of the protein sequences of orthologues of the mouse BID protein showing known peptidase cleavages. The
alignment is highlighted to show conservation of residues around the cleavage of BID by cathepsin H (C01.040) at residue 12.
The sequence where the cleavage is known is highlighted in green and residues are numbered according to this sequence (inserts
are indicated by letters). The rows beneath the residue numbers show the MEROPS identifier of each peptidase known to cleave
this substrate. Arrows indicate the residue range of the fragment used in the experiment, and cleavage positions are indicated
by the ‘+’ symbol. Clicking on a MEROPS identifier takes the user to the relevant summary page. Clicking on a ‘+’ symbol causes
the alignment to be redrawn with residues P4–P40 highlighted for that particular cleavage. Residues either side of the cleavage
site are highlighted in pink if conserved with the equivalent residue in the sequence where the cleavage is known. A residue is
highlighted in orange if it is not conserved but is known to occur in the same binding pocket in another cathepsin H substrate.
A residue is shown as white on black if it is not conserved and is not known to occur in the same peptidase substrate binding site
in any other substrate.
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.............................................................................................................................................................................................................................................................................................Where it is possible to suggest a cause why a cleavage
site is not conserved this is indicated in Table 4 by the let-
ters a–h. Included in category d, where insertions and or
deletions occur in the homologous cleavage sites, is 50S
ribosomal protein L7Ae (UniProt accession P12743). There
are N-terminal extensions to most homologues so that the
known methionyl aminopeptidase 2-cleavage site is not
aligned. Five of these sequences may be derived from erro-
neous gene builds (point b). The UniRef50 database entry
for 60S ribosomal protein L10 (P27635) includes a wide
range of species (the cleavage is known in the human pro-
tein) and the peptidase performing the cleavage (granzyme
B) is not present in Paracoccidiodes brasiliensis, where the
substrate cleavage is also not conserved. The replacements
that are reported as atypical in hemoglobin subunit alpha
(P69905) by Schistosoma cathepsin D (A01.009) (34) are
the rarest naturally occurring amino acids, tryptophan
and cysteine, and despite there being 109 known cleavages
for this peptidase, this may still not be enough to properly
exclude these rare amino acids. On the other hand, this is
the cleavage of a host protein by a parasite peptidase and
the specificity may have adapted to limit the availability
of hosts.
None of the cleavages listed in Table 4 has been assigned
to cause f above, namely where changes in the substrate
cleavage site may be mirrored by changes in peptidase spe-
cificity. Without modelling the substrate binding sites, if
that were possible, detecting this situation is difficult.
However, the autolytic processing of cathepsin E (P43159)
may be such an example (35).
In some cases, a poorly conserved cleavage site may
represent a pathological condition in the species where
the cleavage was first identified. For example, despite
there being few cleavages for cathepsin H, the reported
cleavages in the BID protein (36) are in particularly poorly
conserved regions (see Figure 3). Cleavage of the BID
protein leads to the induction of apoptosis. That the cleav-
age sites are not well conserved amongst mammalian
orthologues is not surprising given that the cytoplasmic
substrate and the lysosomal peptidase should not meet
under normal circumstances. The mouse protein in which
the cleavage was identified may therefore be unusually
susceptible to cleavage should the lysosomal membrane
be ruptured.
The specificity logos and frequency matrices for all pep-
tidases with 10 or more known substrate cleavages are
already available in the MEROPS database. Alignments
are also available for all protein substrates that have a cor-
responding UniRef50 entry, showing conservation of both
physiological and non-physiological cleavages. The next
release of the database will include tables showing compar-
ative peptidase specificity in terms of preference for both
amino acid and amino acid type.
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.............................................................................................................................................................................................................................................................................................Conclusions
The MEROPS database includes over 39 000 cleavages in
substrates (synthetic and naturally occurring) which have
been collected from the literature. These are classified as
physiological or non-physiological, depending on whether
the substrate is naturally occurring and if it is in native con-
formation. At least one substrate is known for 45% of the
different peptidases identified in the MEROPS database.
Displays in the database give insights into peptidase speci-
ficity and to the conservation of cleavage sites amongst
orthologous proteins. The data provide a substantial train-
ing set for algorithms to predict peptidase substrates and
cleavage positions in those substrates. The data may also be
useful for the design of inhibitors and engineering novel
specificities into peptidases.
By examining the conservation of cleavage sites in pro-
tein substrates in terms of peptidase substrate binding sites,
it is clear that there are a number of cleavages where atyp-
ical replacements occur. Many of these can be explained by
gene build or sequencing errors, inserts or deletions in the
region around the cleavage site, or the alignments contain
one or more paralogues in which cleavage may be absent
or different. In a few cases it is possible that more than one
peptidase is involved in processing, or there may not be
enough known substrates for some peptidases to be sure
that an atypical replacement is really unacceptable. A
number of substrate cleavages that may be fortuitous and
not of any physiological relevance have been identified.
This cleavage set is freely available and can be down-
loaded from the MEROPS FTP site (ftp://ftp.sanger.ac.uk/
pub/MEROPS/current_release/database_files/
Substrate_search.txt).
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